Bill Status of SB2535  102nd General Assembly


Short Description:  CONTROLLED SUBSTANCE-PRESCRIBE

Senate Sponsors
Sen. Melinda Bush - Christopher Belt - Sara Feigenholtz - Michael E. Hastings - Jacqueline Y. Collins, Rachelle Crowe, Cristina Castro, Robert Peters, Karina Villa, Laura Ellman, Linda Holmes, Robert F. Martwick, Chapin Rose, Jason A. Barickman and John Connor

House Sponsors
(Rep. Deb Conroy, Robyn Gabel, Lindsey LaPointe, Curtis J. Tarver, II, Jeff Keicher, Mark Batinick, Chris Bos, Ann M. Williams, Kathleen Willis and Terra Costa Howard)

Last Action
DateChamber Action
  6/2/2022SenatePublic Act . . . . . . . . . 102-1040

Statutes Amended In Order of Appearance
720 ILCS 570/322 new


Synopsis As Introduced
Amends the Illinois Controlled Substances Act. Provides that a prescriber shall offer a prescription for naloxone hydrochloride, or another similar drug approved by the Food and Drug Administration, under specified circumstances. Provides for educational information to be provided concerning overdose prevention and the use of naloxone hydrochloride. Provides that a prescriber who does not comply with specified requirements shall be subject to administrative sanctions under the appropriate licensing board. Specifies that the provisions do not create a private right of action against a prescriber, and do not limit a prescriber's liability for the negligent failure to diagnose or treat a patient. Provides that these provisions do apply to a patient receiving hospice care in accordance with the Hospice Program Licensing Act. Contains a purpose provision. Effective immediately.

Senate Floor Amendment No. 2
Deletes reference to:
720 ILCS 570/322 new
Adds reference to:
225 ILCS 85/19.1
720 ILCS 570/312from Ch. 56 1/2, par. 1312
720 ILCS 570/313from Ch. 56 1/2, par. 1313

Replaces everything after the enacting clause. Amends the Pharmacy Practice Act. In a provision regarding dispensing opioid antagonists, provides that notwithstanding any general or special law to the contrary, a licensed pharmacist shall (rather than may) dispense an opioid antagonist in accordance with written, standardized procedures or protocols developed by the Department of Financial and Professional Regulation with the Department of Public Health and the Department of Human Services and filed at the pharmacy. Provides that before dispensing an opioid a pharmacist shall inform patients that opioids are addictive and offer to dispense an opioid antagonist. Deletes language concerning a training program approved by the Department of Human Services for pharmacists to complete before dispensing an opioid. Amends the Illinois Controlled Substances Act. Provides that prescribers who issue a prescription for an opioid shall inform the patient that opioids are addictive and that opioid antagonists are available by prescription or from a pharmacy. Provides that in a hospital or institution licensed under the Hospital Licensing Act, all prescribers of an opioid shall inform the patient that opioids are addictive and that opioid antagonists are available by prescription or from a pharmacy. Provides that upon discharge any patient who has overdosed on controlled substances shall be provided with an opioid antagonist. Provides that if the patient is not able to pay for the opioid antagonist, then the State of Illinois shall reimburse the hospital for the opioid antagonist from federal grant funds to address substance use disorder or other State funds for the same purpose. Adds an effective date provision of January 1, 2022.

Senate Floor Amendment No. 3
Changes the effective date of the bill from January 1, 2022 to January 1, 2023.

Senate Floor Amendment No. 4
Provides that in a hospital or institution licensed under the Hospital Licensing Act, all prescribers of an opioid shall inform the patient that opioids are addictive and that opioid antagonists are available by prescription or from a pharmacy. Provides that upon discharge, any patient who has overdosed on controlled substances shall be provided with an opioid antagonist in accordance with written, standardized procedures or protocols developed by the Department of Financial and Professional Regulation with the Department of Human Services and the Department of Public Health and filed at the pharmacy before implementation and are available to the Department of Human Services upon request. Defines "opioid antagonist".

Senate Floor Amendment No. 5
Deletes reference to:
720 ILCS 570/313

Deletes provisions of the bill, as amended by Senate Amendment No. 2, that relate to prescriptions of opioids in hospitals or institutions licensed under the Hospital Licensing Act and requirements for providing opioid antagonists to patients who are being discharged after having overdosed on controlled substances.

Actions 
DateChamber Action
  2/26/2021SenateFiled with Secretary by Sen. Melinda Bush
  2/26/2021SenateFirst Reading
  2/26/2021SenateReferred to Assignments
  3/17/2021SenateAdded as Co-Sponsor Sen. Sara Feigenholtz
  3/18/2021SenateAdded as Co-Sponsor Sen. Rachelle Crowe
  3/19/2021SenateAdded as Co-Sponsor Sen. Cristina Castro
  4/7/2021SenateAssigned to Licensed Activities
  4/13/2021SenateAdded as Co-Sponsor Sen. Robert Peters
  4/13/2021SenateAdded as Chief Co-Sponsor Sen. Christopher Belt
  4/16/2021SenateRule 3-9(a) / Re-referred to Assignments
  4/20/2021SenateRule 2-10 Committee Deadline Established As April 23, 2021
  4/20/2021SenateRe-assigned to Licensed Activities
  4/20/2021SenateAdded as Chief Co-Sponsor Sen. Sara Feigenholtz
  4/21/2021SenateWaive Posting Notice
  4/21/2021SenateDo Pass Licensed Activities; 006-002-000
  4/21/2021SenatePlaced on Calendar Order of 2nd Reading April 22, 2021
  4/22/2021SenateSecond Reading
  4/22/2021SenatePlaced on Calendar Order of 3rd Reading April 23, 2021
  4/22/2021SenateAdded as Co-Sponsor Sen. Karina Villa
  4/23/2021SenateSenate Floor Amendment No. 1 Filed with Secretary by Sen. Melinda Bush
  4/23/2021SenateSenate Floor Amendment No. 1 Referred to Assignments
  4/23/2021SenateRule 2-10 Third Reading Deadline Established As April 30, 2021
  4/27/2021SenateSenate Floor Amendment No. 1 Assignments Refers to Licensed Activities
  4/28/2021SenateAdded as Co-Sponsor Sen. Laura Ellman
  4/29/2021SenateSenate Floor Amendment No. 1 Recommend Do Adopt Licensed Activities; 007-000-000
  4/29/2021SenateAdded as Chief Co-Sponsor Sen. Michael E. Hastings
  4/30/2021SenateRule 2-10 Third Reading Deadline Established As May 7, 2021
  5/7/2021SenateRule 2-10 Committee/3rd Reading Deadline Established As May 21, 2021
  5/12/2021SenateSenate Floor Amendment No. 2 Filed with Secretary by Sen. Melinda Bush
  5/12/2021SenateSenate Floor Amendment No. 2 Referred to Assignments
  5/14/2021SenateSenate Floor Amendment No. 2 Assignments Refers to Licensed Activities
  5/21/2021SenateRule 3-9(a) / Re-referred to Assignments
  7/16/2021SenateSenate Floor Amendment No. 2 Pursuant to Senate Rule 3-9(b) / Referred to Assignments
  1/5/2022SenateApproved for Consideration Assignments
  1/5/2022SenatePlaced on Calendar Order of 3rd Reading January 5, 2022
  1/5/2022SenateSenate Floor Amendment No. 2 Assignments Refers to Licensed Activities
  2/18/2022SenateAdded as Co-Sponsor Sen. Linda Holmes
  2/18/2022SenateSenate Floor Amendment No. 3 Filed with Secretary by Sen. Melinda Bush
  2/18/2022SenateSenate Floor Amendment No. 3 Referred to Assignments
  2/18/2022SenateAdded as Chief Co-Sponsor Sen. Jacqueline Y. Collins
  2/22/2022SenateSenate Floor Amendment No. 3 Assignments Refers to Licensed Activities
  2/22/2022SenateAdded as Co-Sponsor Sen. Robert F. Martwick
  2/22/2022SenateSenate Floor Amendment No. 4 Filed with Secretary by Sen. Melinda Bush
  2/22/2022SenateSenate Floor Amendment No. 4 Referred to Assignments
  2/23/2022SenateSenate Floor Amendment No. 4 Assignments Refers to Licensed Activities
  2/23/2022SenateSenate Floor Amendment No. 2 Recommend Do Adopt Licensed Activities; 008-000-000
  2/23/2022SenateSenate Floor Amendment No. 3 Recommend Do Adopt Licensed Activities; 008-000-000
  2/23/2022SenateSenate Floor Amendment No. 4 Recommend Do Adopt Licensed Activities; 008-000-000
  2/24/2022SenateAdded as Co-Sponsor Sen. Chapin Rose
  2/24/2022SenateSenate Floor Amendment No. 5 Filed with Secretary by Sen. Melinda Bush
  2/24/2022SenateSenate Floor Amendment No. 5 Referred to Assignments
  2/24/2022SenateAdded as Co-Sponsor Sen. Jason A. Barickman
  2/25/2022SenateRule 2-10 Third Reading Deadline Established As March 11, 2022
  3/2/2022SenateSenate Floor Amendment No. 5 Assignments Refers to Licensed Activities
  3/9/2022SenateSenate Floor Amendment No. 5 Recommend Do Adopt Licensed Activities; 006-000-000
  3/9/2022SenateRecalled to Second Reading
  3/9/2022SenateSenate Floor Amendment No. 2 Adopted; Bush
  3/9/2022SenateSenate Floor Amendment No. 3 Adopted; Bush
  3/9/2022SenateSenate Floor Amendment No. 4 Adopted; Bush
  3/9/2022SenateSenate Floor Amendment No. 5 Adopted; Bush
  3/9/2022SenatePlaced on Calendar Order of 3rd Reading
  3/9/2022SenateThird Reading - Passed; 049-000-000
  3/9/2022SenateSenate Floor Amendment No. 1 Tabled Pursuant to Rule 5-4(a)
  3/10/2022HouseArrived in House
  3/10/2022HouseChief House Sponsor Rep. Deb Conroy
  3/10/2022HouseFirst Reading
  3/10/2022HouseReferred to Rules Committee
  3/11/2022SenateAdded as Co-Sponsor Sen. John Connor
  3/17/2022HouseAssigned to Mental Health & Addiction Committee
  3/23/2022HouseAdded Alternate Co-Sponsor Rep. Robyn Gabel
  3/23/2022HouseAdded Alternate Co-Sponsor Rep. Lindsey LaPointe
  3/24/2022HouseAdded Alternate Co-Sponsor Rep. Curtis J. Tarver, II
  3/24/2022HouseDo Pass / Short Debate Mental Health & Addiction Committee; 016-000-000
  3/24/2022HousePlaced on Calendar 2nd Reading - Short Debate
  3/25/2022HouseSecond Reading - Short Debate
  3/25/2022HousePlaced on Calendar Order of 3rd Reading - Short Debate
  3/29/2022HouseThird Reading - Short Debate - Passed 111-000-000
  3/29/2022SenatePassed Both Houses
  3/29/2022HouseAdded Alternate Co-Sponsor Rep. Jeff Keicher
  3/29/2022HouseAdded Alternate Co-Sponsor Rep. Mark Batinick
  3/29/2022HouseAdded Alternate Co-Sponsor Rep. Chris Bos
  3/29/2022HouseAdded Alternate Co-Sponsor Rep. Ann M. Williams
  3/29/2022HouseAdded Alternate Co-Sponsor Rep. Kathleen Willis
  3/29/2022HouseAdded Alternate Co-Sponsor Rep. Terra Costa Howard
  4/27/2022SenateSent to the Governor
  6/2/2022SenateGovernor Approved
  6/2/2022SenateEffective Date January 1, 2023
  6/2/2022SenatePublic Act . . . . . . . . . 102-1040